Search Results

Researchers engineered stem cell-derived heart tissues to study how tachycardia affects the heart and to uncover the inner workings of our body’s engine.

Scientists gathered to discuss the future of synthetic biology and how it can help curb climate change and promote sustainability.

Credited with sparking the field of genetic engineering, Stanford Medicine biochemist Paul Berg shared the 1980 Nobel Prize in chemistry for creating the first recombinant DNA molecule.

In the five decades since the emergence of recombinant DNA technology, researchers at Stanford Medicine have benefited from the close involvement of bioethics experts.

Stanford Medicine researchers have created a molecule that blocks an enzyme thought to be instrumental in causing colon cancer relapse or chemotherapy resistance.

The California Institute for Regenerative Medicine has awarded $31 million to three Stanford researchers to launch trials of treatments for common diseases. Four other Stanford researchers also received a total of $4.55 million.

CAR-T cell therapy works for many types of blood cancers, but more than half of patients relapse. A Stanford study provides a clue as to why.

Annelise Barron, Peter Kim, Siddhartha Jaiswal and Keren Haroush will receive grants totaling $10 million to fund their investigations. The awards support risky efforts that could potentially have a big impact in the biomedical sciences.

No one knows exactly how flatworms can rebuild their entire bodies from the tiniest sliver. Now, bioengineers and materials scientists are building new tools to study the worms’ awesome regenerative powers.

The award, which includes a gift of 100 million yen (about $913,000), recognizes the neuroscientist for pioneering and advancing a technology for studying brain circuits.